A new vaccine is out just in time for fall, offering protection against the latest variant. Anyone 6 months and older can get ...

Flu season approaches and there's a new COVID variant. The time to act is now, or soon, according to the two largest local hospital systems.

COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, ...

Two new COVID-19 strains are circulating globally. Here's what we know about them and what experts anticipate.

This page requires JavaScript to be enabled to properly display data shown within components like charts, tables, etc.. Circulation of respiratory viruses is normally ...

Merck (MRK) closed the most recent trading day at $117.84, moving -0.63% from the previous trading ... sector's gain of 5.85% and the S&P 500's gain of 6.22%. The upcoming earnings release of ...

The Centers for Disease Control and Prevention does not have a preference for one vaccine over the other, and both are recommended for anyone 6 months and older. The FDA also issued an Emergency ...

Some 3.6 million mpox vaccine doses have been secured for African countries, according to the Africa CDC, with the DRC being a priority. Sixty two percent of the mpox cases in DRC have been ...

Merck & Co’s CEO Kenneth Frazier has warned that the drugs and vaccines in the pipeline to combat COVID-19 may not be enough to swiftly end the pandemic. Speaking to CNBC, Frazier said that the ...

Now, new research from the drug company Moderna suggests its new mpox vaccine, based on mRNA technology, might do a better job at shielding recipients from harm. The findings were published Sept ...

2 strain of SARS-CoV-2. These vaccines are manufactured by Moderna and Pfizer, and have been authorized for use in those 12 ...

Scientists in many fields received little recognition for the last couple of years, as the world focused on the emergency push to develop vaccines and treatments for Covid-19. But that doesn't ...